Your browser doesn't support javascript.
loading
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Gionfriddo, Ilaria; Brunetti, Lorenzo; Mezzasoma, Federica; Milano, Francesca; Cardinali, Valeria; Ranieri, Roberta; Venanzi, Alessandra; Pierangeli, Sara; Vetro, Calogero; Spinozzi, Giulio; Dorillo, Erica; Wu, Hsin Chieh; Berthier, Caroline; Ciurnelli, Raffaella; Griffin, Melanie J; Jennings, Claire E; Tiacci, Enrico; Sportoletti, Paolo; Falzetti, Franca; de Thé, Hugues; Veal, Gareth J; Martelli, Maria Paola; Falini, Brunangelo.
Afiliação
  • Gionfriddo I; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Brunetti L; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Mezzasoma F; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Milano F; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Cardinali V; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Ranieri R; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Venanzi A; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Pierangeli S; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Vetro C; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Spinozzi G; Hematology, A.O. "Policlinico S. Marco", Catania, Italy.
  • Dorillo E; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Wu HC; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Berthier C; INSERM U944 and 1050, IRSL, University of Paris and PSL, Hôpital St. Louis and Collége de France, Paris, France.
  • Ciurnelli R; INSERM U944 and 1050, IRSL, University of Paris and PSL, Hôpital St. Louis and Collége de France, Paris, France.
  • Griffin MJ; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Jennings CE; Newcastle University Centre for Cancer, Newcastle University, Newcastle, UK.
  • Tiacci E; Newcastle University Centre for Cancer, Newcastle University, Newcastle, UK.
  • Sportoletti P; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Falzetti F; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • de Thé H; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy.
  • Veal GJ; INSERM U944 and 1050, IRSL, University of Paris and PSL, Hôpital St. Louis and Collége de France, Paris, France.
  • Martelli MP; Newcastle University Centre for Cancer, Newcastle University, Newcastle, UK.
  • Falini B; Hematology, Center for Research in Hemato-Oncology (CREO), University of Perugia, Perugia, Italy. maria.martelli@unipg.it.
Leukemia ; 35(9): 2552-2562, 2021 09.
Article em En | MEDLINE | ID: mdl-33654209
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Nucléolo Celular / Resistencia a Medicamentos Antineoplásicos / Dactinomicina / Mutação / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Nucléolo Celular / Resistencia a Medicamentos Antineoplásicos / Dactinomicina / Mutação / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália